Table 1. Asymmetric Addition of Acetate 2 to (R)-1 (3.6 equiv)
entry
2
R1
R2
4a (%)
deb,c (%)
6 (%)
8 (%)
9 (%)
1
2
3
4
5
6
a
b
c
d
e
f
phenyl
phenyl
3,4-dimethoxyphenyl
pyridin-3-yl
fur-2-yl
Ph-CHdCH-
Me
t-Bu
Me
t-Bu
Me
Me
22
24
23
37
18
85 (>95)
>95 (>95)
86 (>95)
>95 (>95)
86 (>95)
2
50
51
27
29
33
6
2
5
3
5
1
6
25
a Yields are of isolated product. b Determined by 1H NMR spectroscopic analysis, and refer to (4S,5S)-4 over (4R,5S)-5, the only δ-amino acid
diastereoisomers detected. Even when the minor one could not be totally isolated, it was possible to determine its presence in the chromatography enriched
fraction or it could be obtained by base treatment of (4S,5S)-4 producing partial epimerisation at C-4. c Values in parenthesis after careful column chromatography
and in some cases crystallization from EtOAc/hexane.
dition,7 and Ireland-Claisen rearrangement/Schmittel cy-
clization.8 However, we report here the first one-pot highly
asymmetric Ireland-Claisen rearrangement/Michael addition
domino reaction, which, starting from readily accessible
acetylated Baylis-Hillman adducts, yields nonracemic δ-
amino acids (Scheme 1). These compounds could find
receptor antagonists (these are of continuing interest14 since
the natural ligand for the NK1 receptor, Substance P, has
been implicated in the pathophysiology of a wide of disease
conditions including neurogenic inflammation, transmission
of pain, emesis, and depression15) or the potent antimalarial
agent (+)-febrifugine,16 first reported as a metabolite of the
Chinese medicinal plant Dichroa febrifuga.17
Baylis-Hillman adducts have been obtained according to
the literature procedure;18 subsequent acetylation furnishes
the acetyl derivatives 2, which upon isomerization using
DABCO19 or CsF20 afford the trisubstituted olefins 3
(Scheme 1, Table 1 and 2). We obtained the δ-amino acid 4
by reaction of the above-mentioned acetates with chiral
lithium amide (R)-1, using sequential addition of n-butyl-
lithium in tetrahydrofuran at -78 °C to the chiral amine and
then adding the acetate (2 or 3) in tetrahydrofuran. As shown
Scheme 1. Asymmetric Synthesis of γ-Substituted δ-Amino
Acids and Transformation to 2,3-Disubstituted Piperidines
(6) Magriotis, P. A.; Kin, K. D. J. Am. Chem. Soc. 1993, 115, 2972–
2973.
(7) (a) Frank, S. A.; Works, A. B.; Roush, W. R. Can. J. Chem. 2000,
78, 757–771. (b) Soldermann, N.; Velker, J.; Vallat, O.; Stoeckli-Evans,
H.; Neier, R. HelV. Chim. Acta 2000, 83, 2266–2276.
(8) Yang, Y.; Petersen, J. L.; Wang, K. K. J. Org. Chem. 2003, 68,
8545–8549.
(9) Schwalbe, H.; Wermuth, J.; Richter, C.; Szalma, S.; Eschenmoser,
A.; Quinkert, G. HelV. Chim. Acta 2000, 83, 1079–1107.
(10) (a) Gellman, S. H. Acc. Chem. Res. 1998, 31, 173–180. (b) Horne,
W. S.; Price, J. L.; Keck, J. L.; Gellman, S. H. J. Am. Chem. Soc. 2007,
129, 4178–4180.
(11) (a) Genest, N.; Lubell, W. D. J. Pept. Sci. 2007, 13, 355–366. (b)
Sasaki, Y.; Niida, A.; Tsuji, T.; Shigenaga, A.; Fujii, N.; Otaka, A. J. Org.
Chem. 2006, 71, 4969–4979. (c) Lee, K. W.; Choi, H. W.; Lee, B. H.;
Choi, B. S.; Chang, J. H.; Kim, Y. K.; Lee, J. H.; Heo, T. H.; Nam, D. H.;
Shin, H. Synlett 2005, 20, 3136–3138.
(12) Lummis, S. C. R.; Beene, D. L.; Lee, L. W.; Lester, H. A.;
Broadhurst, R. W.; Dougherty, D. A. Nature 2005, 438, 248–252.
(13) Trabocchi, A.; Menchi, G.; Guarna, F.; Machetti, F.; Scarpi, D.;
Guarna, A. Synlett 2006, 331–353.
(14) Raubo, P.; Kulagowski, J. J.; Chicchi, G. G. Synlett 2006, 271–
274.
(15) Seward, E. M.; Swain, C. J. Expert Opin. Ther. Pat. 1999, 9, 571–
582.
various applications in organic and peptidomimetic synthesis:
for example, as monomers for the generation of oligomers9
that display a variety of specific secondary structures (named
“foldamers” by Gellman),10 as substituted ethylene dipeptide
isosteres,11 these isomeric peptides show different biological
functions,12 as chiral auxiliaries in asymmetric synthesis,13
and in the asymmetric synthesis of 2,3-disubstituted pip-
eridines (Scheme 1). Some of these have been the object of
considerable synthetic effort, such as for neurokinin-1 (NK1)
(16) Michael, J. P.; Koning, Ch. B.; Pienaar, D. P. Synlett 2006, 383–
386.
(17) Koepfli, J. B.; Brockman, J. A., Jr.; Moffat, J. J. Am. Chem. Soc.
1950, 72, 3323–3323.
(18) (a) For relevant reviews see : Basavaiah, D.; Rao, A. J.; Satya-
narayana, T. Chem. ReV. 2003, 103, 811–891. (b) Basavaiah, D.; Dharma
Rao, P.; Suguna Hymna, R. Tetrahedron 1996, 52, 8001–8062. (c) Ciganek,
E. Organic Reactions; Paquette, L. A., Ed.; Wiley: New York, 1997; Vol
51, p 201.
(19) Mason, P. H.; Emslie, N. Tetrahedron 1994, 50, 12001–12008.
(20) Foucaud, A.; El Guemmout, F. Bull. Soc. Chim. Fr. 1989, 403–
408.
1688
Org. Lett., Vol. 10, No. 9, 2008